VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Apr 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-04-23

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-23	Common Stock	S	65	$35.82	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	632830	Direct
Common Stock	13286	Indirect
Common Stock	300000	Indirect

Footnotes

F1: Sale of 65 shares of common stock by an estate in which Dr. Boger is one of the beneficiaries.

F2: Common stock held in grantor retained annuity trusts.